S 677 Massachusetts Senate · 193rd Legislature (2023-2024)

An Act relative to prescription-drug utilization review

This bill amends Massachusetts insurance laws to restrict when health plans can require prior authorization for prescription drugs, specifically banning it for generic non-controlled medications, drugs taken continuously for six months, and certain long-acting injectable antipsychotics. It also limits retrospective reviews of already-paid claims unless there is credible evidence of fraud or if the treatment exceeded the originally approved scope. Additionally, the legislation mandates that any adverse decision on a drug request must be reviewed by a physician in the same specialty as the prescribing doctor and establishes a faster grievance process that automatically approves the drug if the insurer does not respond within 48 hours.
Bill status passed 3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Feb 2023
House Passage
Feb 2023
Governor
Introduced Feb 16, 2023 Last action Feb 12, 2024
Floor votes

How they voted

This bill passed the House. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
4
Key actions
1
Committee
1
Feb 16, 2023
House · Passed
House concurred
Feb 16, 2023
Senate · Referred to committee
Referred to the committee on Financial Services
1 primary · 0 co-sponsors

Sponsors